The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Comparison of Effects of Angiotensin I– Converting Enzyme Inhibition and β-Blockade for 2 Years on Function of Small Arteries From Hypertensive Patients
Abstract
The effect of treatment with two different antihypertensive agents on the function of small arteries from 17 patients with essential hypertension randomly assigned to receive either the angiotensin I–converting enzyme inhibitor cilazapril or the β-blocker atenolol was investigated. Subcutaneous small arteries obtained from gluteal fat biopsies were studied on a wire myograph before treatment and at 1 and 2 years of treatment. Blood pressure was mildly elevated in both groups of patients (mean, 150/100 mm Hg) and was well controlled throughout the 2 years of treatment (mean, 130/85 mm Hg). We previously reported, in arteries from patients treated with cilazapril, an improvement at 1 year of treatment of the vasoconstrictor effect of endothelin-1, which had been significantly attenuated in the untreated hypertensive patients compared with normotensive subjects. After 2 years of treatment, this normalization of endothelin-1 response was still present in small arteries of patients treated with the angiotensin I–converting enzyme inhibitor, whereas in patients treated with atenolol, responses were still unchanged after 2 years of treatment. Endothelial function was tested by examining the response of norepinephrine-precontracted arteries to acetylcholine. Untreated hypertensive patients exhibited a slightly but significantly blunted vasorelaxation in response to 10 μmol/L acetylcholine compared with normotensive subjects. After 1 and 2 years of effective antihypertensive treatment, cilazapril-treated patients exhibited responses to acetylcholine that were not different from those of normotensive subjects, whereas atenolol-treated patients still had impaired responses. Thus, together with the correction of the structure of small arteries that we previously reported occurs after 1 or 2 years of treatment with cilazapril, there is persistent normalization of endothelin-1–mediated vasoconstriction and slight improvement of endothelium-dependent vasorelaxation. This suggests that impaired smooth muscle and endothelial function in small arteries of patients with essential hypertension may be corrected by treatment with angiotensin I–converting enzyme inhibitors but not with β-blockers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768
Cited by
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328333146d · Cited by 1,643
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Intengan, H. D., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.096249 · Cited by 979
Self-citationTouyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Self-citationFeasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
Julius, S., Nesbitt, S. D., Egan, B. M., Weber, M. A., Michelson, E. L., Kaciroti, N., Black, H. R., Grimm, R. H., Messerli, F. H., Oparil, S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060838 · Cited by 924
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Blood Pressure · doi:10.3109/08037050903450468 · Cited by 894
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818
Endothelial Function and Oxidative Stress in Cardiovascular Diseases
Higashi, Y., Noma, K., Yoshizumi, M., & Kihara, Y. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1102 · Cited by 798
Schiffrin, E. L., Park, J. B., Intengan, H. D., & Touyz, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.14.1653 · Cited by 616
Self-citationPrognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women
Modena, M. G., Bonetti, L., Coppi, F., Bursi, F., & Rossi, R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01976-9 · Cited by 575
Endothelial Function and Oxidative Stress in Renovascular Hypertension
Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Oshima, T., & Chayama, K. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013591 · Cited by 544
(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.003 · Cited by 331
Vasopeptidase Inhibitors: A New Therapeutic Concept in Cardiovascular Disease?
Corti, R., Burnett Jr, J. C., Rouleau, J. L., Ruschitzka, F., & Lüscher, T. F. (2001) · Circulation · doi:10.1161/hc4001.097191 · Cited by 300
Vascular Remodeling in Hypertension: Mechanisms and Treatment
Schiffrin, E. L. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.187021 · Cited by 276
Self-citationVascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension
Brown, I. A. M., Diederich, L., Good, M. E., DeLalio, L. J., Murphy, S. A., Cortese-Krott, M. M., Hall, J. L., Le, T. H., & Isakson, B. E. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311229 · Cited by 266
Higashi, Y., & Yoshizumi, M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.02.003 · Cited by 262
Schiffrin, E. L., & Touyz, R. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00262.2004 · Cited by 253
Self-citationHigashi, Y., Sasaki, S., Nakagawa, K., Fukuda, Y., Matsuura, H., Oshima, T., & Chayama, K. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02317-2 · Cited by 173
Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Kajiyama, G., & Oshima, T. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01288-1 · Cited by 136
Higashi, Y. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02191-4 · Cited by 125
In-depth analysis of lupeol: delving into the diverse pharmacological profile
Dalimunthe, A., Carensia Gunawan, M., Dhiya Utari, Z., Dinata, M. R., Halim, P., Estherina S. Pakpahan, N., Sitohang, A. I., Sukarno, M. A., Yuandani, Harahap, Y., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1461478 · Cited by 50
Metadata
- Authors
- Schiffrin, E. L., & Deng, L.-Y.
- Venue
- Hypertension
- Published
- 1995-04
- Volume
- 25
- Issue
- 4
- Pages
- 699-703
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2041037406
- Cited by
- 192
- References
- 1
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.